Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Burkina Faso
MUAC-Only
Effectiveness of an Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Passore Province (Northern Region), Burkina Faso
1 other identifier
interventional
4,958
1 country
1
Brief Summary
MUAC only is a pilot trial external control carried out between January 2017 and December 2017 in the Yako district (northern region), Burkina Faso. The objective of this study is to evaluate an integrated protocol for acute malnourished children without medical complication. The hypotheses of the integrated protocol include :
- 1.A global treatment of acute malnutrition (moderate and severe) with a single treatment (RUTF) would improve the functioning of the program through early identification of acutely malnourished children, while achieving a better coverage and using a single supply chain.
- 2.A gradual reduction of RUTF dosage according to a child's MUAC status could significantly increase the number of children on treatment without increasing overall RUTF quantity while maintaining similar recovery rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 17, 2017
CompletedFirst Posted
Study publicly available on registry
January 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedJanuary 30, 2019
January 1, 2019
11 months
January 17, 2017
January 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recovery rate
The recovery is defined as below : * Minimum of 4 weeks of participation in the program * MUAC\> = 125 mm on 2 consecutive visits * No edema for minimum 2 weeks * Good Clinical Health
Between 4 and 12 weeks
Secondary Outcomes (6)
Mortality rate
Between inclusion and week 12
Default rate
Between 3 and 12 weeks
Non-respondent rate
12 weeks after inclusion
Hospitalization rate
Between inclusion and week 12
Relapse rate
up to 3 months
- +1 more secondary outcomes
Study Arms (1)
MUAC<125mm
EXPERIMENTALno medical complication
Interventions
MUAC used as the primary admission and exit criteria for children with MUAC \<125mm and no medical complication. Single treatment of RUTF for severe and moderate malnourished children and gradual reduction of doses according to the MUAC and the weight of the child during treatment. MUAC split into 3 categories: * MUAC \<115 mm: 175 kcal /kg/day * 115 \<MUAC \<120mm: 125kcal/kg/day * 120 \<MUAC \<125mm: 75kcal/kg/day
Eligibility Criteria
You may qualify if:
- Being between 6 and 59 months old
- New admission
- Acute malnutrition defined as follows:
- MUAC\<125mm
- MUAC\> 125mm AND WHZ (Z-score) \<-3 (WHO standard)
- Edema
- Resident in the study area (Yako district)
- Signed informed consent of the mother or the child's guardian
You may not qualify if:
- Children allergic to milk, peanuts and / or RUTF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alliance for International Medical Actionlead
- Institut National de la Santé Et de la Recherche Médicale, Francecollaborator
- Association Keoogocollaborator
- Institut de Recherche en Sciences de la Sante, Burkina Fasocollaborator
- SOS médecins Burkina Fasocollaborator
Study Sites (1)
ALIMA
Yako, Nord Region, Burkina Faso
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Shepherd, MD
Directrice de recherches Opérationnelles et Médicales, ALIMA, USA
- PRINCIPAL INVESTIGATOR
Renaud Becquet, MPH,PhD,HDR
Chercheur Inserm, Inserm U1219 Bordeaux Population Health Center-Université de Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2017
First Posted
January 23, 2017
Study Start
January 1, 2017
Primary Completion
December 1, 2017
Study Completion
April 1, 2018
Last Updated
January 30, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share